BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/18/2020 5:58:43 AM | Browse: 653 | Download: 1234
 |
Received |
|
2020-07-10 12:13 |
|
Peer-Review Started |
|
2020-07-10 12:13 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-10-06 16:39 |
|
Revised |
|
2020-10-16 04:43 |
|
Second Decision |
|
2020-10-30 10:29 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-10-30 22:41 |
|
Articles in Press |
|
2020-10-30 22:41 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-12-14 01:24 |
|
Publish the Manuscript Online |
|
2020-12-18 05:58 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Cory Higley, Christine C Hsu, Coleman Smith, Sandeep Nadella and Alexander T. Lalos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Cory Higley, Consultant, Attending Doctor, Department of Medicine, MedStar Georgetown University Hospital, 3800 Reservoir Rd NW
PHC 5, Washington, DC 20007, United States. cory.higley@gunet.georgetown.edu |
| Key Words |
Sofosbuvir/velpatasvir/voxilaprevir; Hepatitis C; Liver transplant; Direct-acting antiviral; Drug-drug interactions; Case report |
| Core Tip |
There have been limited reports published on the use of sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) for the treatment of hepatitis C virus in post-liver transplant patients who had previous direct-acting antiviral failure prior to transplant. Herein, we present what we believe to be the largest case series of SOF/VEL/VOX use in these patients and highlight its efficacy and safety. More so, we discuss potential drug-drug interactions between SOF/VEL/VOX and common immunosuppression regimens. |
| Publish Date |
2020-12-18 05:58 |
| Citation |
Higley C, Hsu CC, Smith C, Nadella S, Lalos A. Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports. World J Hepatol 2020; 12(12): 1341-1348 |
| URL |
https://www.wjgnet.com/1948-5182/full/v12/i12/1341.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v12.i12.1341 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
